Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Video: Pluristem Says Its Placental Stem Therapy Offers "Off The Shelf" Promise

This article was originally published in The Pink Sheet Daily

Executive Summary

Pluristem Therapeutics Chairman and CEO Zami Aberman explains how stem cell therapy will shape the industry, in a recent interview at the Biotech Showcase.


Related Content

Pluristem Fast Forwards Placental Cell Therapy Into US-EU Pivotal Trial


Related Companies